Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/115941
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Nicholls, S. | - |
| dc.contributor.author | Ray, K. | - |
| dc.contributor.author | Ballantyne, C. | - |
| dc.contributor.author | Beacham, L. | - |
| dc.contributor.author | Miller, D. | - |
| dc.contributor.author | Ruotolo, G. | - |
| dc.contributor.author | Nissen, S. | - |
| dc.contributor.author | Riesmeyer, J. | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Atherosclerosis, 2017; 261:12-18 | - |
| dc.identifier.issn | 0021-9150 | - |
| dc.identifier.issn | 1879-1484 | - |
| dc.identifier.uri | http://hdl.handle.net/2440/115941 | - |
| dc.description.abstract | Abstract not available | - |
| dc.description.statementofresponsibility | Stephen J. Nicholls, Kausik K. Ray, Christie M. Ballantyne, Lauren A. Beacham, Debra L. Miller, Giacomo Ruotolo, Steven E. Nissen, Jeffrey S. Riesmeyer (for theACCENTUATE Investigators) | - |
| dc.language.iso | en | - |
| dc.publisher | Elsevier | - |
| dc.rights | © 2017 Elsevier B.V. All rights reserved. | - |
| dc.source.uri | http://dx.doi.org/10.1016/j.atherosclerosis.2017.04.008 | - |
| dc.subject | CETP; clinical trials; lipids; cardiovascular disease | - |
| dc.title | Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trial | - |
| dc.type | Journal article | - |
| dc.identifier.doi | 10.1016/j.atherosclerosis.2017.04.008 | - |
| pubs.publication-status | Published | - |
| dc.identifier.orcid | Nicholls, S. [0000-0002-9668-4368] | - |
| Appears in Collections: | Aurora harvest 8 Medicine publications | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.